Single vs. Dual-DCCV in Obese Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT04539158

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Dr. Daniel P Morin, MD MPH FHRS (from the registry)
Registry
  • NCT NCT04539158
Other papers using this trial's data
  • Dual vs Single Cardioversion of Atrial Fibrillation in Patients With Obesity: A Randomized Clinical Trial JAMA cardiology, 2024-07-01 DOI, PubMed 38776097, PMC11238033 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04539158. Randomized; single masking; primary purpose treatment. Start 2020-08-07 (actual); primary completion 2023-07-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Single vs. Dual-DCCV in Obese Patients
Intervention (Device)
Direct Current Cardioversion
Lead sponsor
Dr. Daniel P Morin, MD MPH FHRS (class: other)

Record details

Record id
cardio:ct-nct04539158
Content hash
a3da518e25010ce9f0666f7917f01f9dbab5ebd7b24723f9a9e8ed54ac897bdb